Investigating the Efficacy of Caloric Vestibular Stimulation in the Treatment of Substance Use Disorders
Withdrawn before enrolling · Not applicable · Has a placebo group
Conditions studied: Substance Use Disorders
In brief
The purpose of this study is to determine efficacy and effect of CVS (caloric vestibular stimulation)
Key facts
- Study ID
- NCT03652311
- Run by
- Wake Forest University Health Sciences
- People needed
- 0
- Starts
- 2019-11-01
- Expected to finish
- 2020-01-01
- Last updated by the study team
- 2019-11-26
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Subjects will have a diagnosed SUD (including but not limited to Opiate, Alcohol, Cocaine, Nicotine, or Amphetamine Use Disorders).
- Subjects will be between the age of 17 and 50 years old
- Subjects will have been abstinent on a stable treatment regimen for at least 4 weeks
- Subjects will be able to sit still for MRI imaging
- Subjects will be able to read and complete survey questionnaires
- Subjects will reliably be abstinent from their drug of choice through the 5 day intervention as determined by the discretion of a clinician
You may not qualify if…
- Subjects will be excluded for comorbid neuropathology (eg history of stroke or TBI)
- Subjects will be excluded if they are at high risk for relapse as determined by a clinician
- Subjects will be excluded if they are unable to tolerate the CVS devise
- Subjects will be excluded if they have malformations of or existing trauma to the external auditory canal
Where it is running
- Wake Forest University Health Sciences — Winston-Salem, North Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.